This inventor holds 1 USPTO granted patent. Top assignees: Fujifilm Corporation, Tokushima University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2024
Title: Tetsuya Ikemoto: Innovator in Insulin-Producing Cell Technology
Introduction
Tetsuya Ikemoto is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of biotechnology, particularly in the production of insulin-producing cells. His innovative work aims to address critical health issues related to diabetes.
Latest Patents
Tetsuya Ikemoto holds a patent for a method of producing insulin-producing cells from mesenchymal stem cells. The patent, titled "Method for producing insulin-producing cell from mesenchymal stem cell, insulin-producing cell, cell structure, and pharmaceutical composition," outlines a process that includes several key steps. These steps involve incubating biocompatible macromolecular blocks with mesenchymal stem cells and culturing these cells in specific media to enhance their glucose responsiveness. This invention is crucial for developing effective treatments for diabetes.
Career Highlights
Throughout his career, Tetsuya Ikemoto has worked with notable organizations, including Fujifilm Corporation and Tokushima University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Tetsuya Ikemoto has collaborated with esteemed colleagues, including Kentaro Nakamura and Mitsuo Shimada. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Tetsuya Ikemoto's work in the field of insulin-producing cell technology represents a significant advancement in biotechnology. His innovative methods and collaborations continue to pave the way for future research and development in diabetes treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile